CABR earnings analysis
What we found in CABR's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.
Our reading of the filing · Free to read, no account needed
The filing does not provide income-statement, segment, balance-sheet or cash-flow figures in the extracted text, so revenue, margins, EPS and free cash flow cannot be assessed. The dominant developments are severe listing and financing risks: Nasdaq denied continued listing after citing the $2.5 million equity requirement, although trading remains stayed pending an August 25, 2026 hearing. The company also reported ineffective disclosure controls due to two material weaknesses, while stating that a significant portion of its $3,235,692 net offering proceeds remained available for operations.
The parts that mattered.
Pulled out of the filing itself, with the figures the company reported.
- Nasdaq hearing stays trading suspension
- The company timely requested a Nasdaq hearing, which stayed suspension of trading and the filing of Form 25-NSE pending the Panel’s decision. The hearing is scheduled for August 25, 2026.
- $3.24 million offering proceeds available
- The November 2025 public offering generated $4,000,000 of gross proceeds and $3,235,692 of net proceeds after $764,308 of discounts, commissions and expenses.
- Unutilized offering cash supports operations
- Management stated that a significant portion of the $3,235,692 net offering proceeds remained unutilized and was held as cash and cash equivalents as of June 30, 2026.
And the other side of it.
The offsets in the same document — the things a summary that only listed the good news would have left out.
- Nasdaq equity deficiency threatens listing
- The company is not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires at least $2.5 million of stockholders’ equity. Nasdaq denied continued-listing relief on July 15, 2026 because the company lacked a definitive financing agreement.
- Appeal failure could cause delisting
- If the Nasdaq appeal is unsuccessful, the company’s common stock could be suspended and delisted, reducing liquidity and impairing its ability to raise capital. The Nasdaq Panel hearing is scheduled for August 25, 2026, and any exception may be subject to milestones.
- Potential $5 million market-value rule
- A newly approved Nasdaq rule would require at least $5 million of market value of listed securities and could trigger immediate suspension and delisting after 30 consecutive business days below the threshold. The rule’s approval order was stayed on July 29, 2026 and is not currently effective.
- Material weaknesses in internal controls
- Disclosure controls and procedures were ineffective as of June 30, 2026 because the internal-control system failed to identify multiple auditor-identified journal entries and lacked a formal related-party transaction approval process.
What they said about what is next.
No quantitative revenue or EPS outlook was provided in the extracted 10-Q. The report states that remaining offering proceeds will support ongoing operations, product development and potential strategic initiatives.
The filing reads worse than the one before it.
What came before.
- 10-Q · May 12, 2026
- The extracted 10-Q text does not include income-statement, segment, balance-sheet, or cash-flow data, so revenue, margins, EPS, and free cash flow cannot be assessed. Liquidity was supported by the November 2025…
- 10-K · March 31, 2026
- Caring Brands remains an extremely early-stage wellness-products company: 2025 revenue was only $4,215 against a $6,278,191 net loss, negative $1,692,258 operating cash flow, and a $5,935,025 operating loss. The IPO…
- 10-Q · November 14, 2025
- The provided filing excerpt does not include the financial statements, income statement trends, segment results, balance sheet, or cash-flow data, so operating performance cannot be assessed. The principal disclosed…
This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.
Read the next one first.
We read every filing CABR makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.
Cancel anytime · Month to month · Switch tiers whenever